EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-Mo Open Label Extension Of PRX-03140 For Alzheimer's Disease Patient Last update: 10/16/2009 12:48:47 PM
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.